Decheng Capital LLC Beyond Spring Inc. Call Options Transaction History
Decheng Capital LLC
- $326 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BYSI
# of Institutions
22Shares Held
5.77MCall Options Held
53.2KPut Options Held
2.5K-
Citigroup Inc454KShares$931,2120.0% of portfolio
-
Black Rock Inc. New York, NY215KShares$441,4770.0% of portfolio
-
Tanaka Capital Management Inc New York, NY29.5KShares$60,4190.17% of portfolio
-
Geode Capital Management, LLC Boston, MA24.4KShares$49,9540.0% of portfolio
-
Northern Trust Corp Chicago, IL16.9KShares$34,6260.0% of portfolio
About BeyondSpring Inc.
- Ticker BYSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,928,900
- Market Cap $79.8M
- Description
- BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...